Diabetes Mellitus, Smoking Status, and Rate of Sputum Culture Conversion in Patients with Multidrug-Resistant Tuberculosis: A Cohort Study from the Country of Georgia

被引:34
作者
Magee, Matthew J. [1 ,2 ]
Kempker, Russell R. [3 ]
Kipiani, Maia [4 ]
Tukvadze, Nestani [4 ]
Howards, Penelope P. [1 ]
Narayan, K. M. Venkat [1 ,2 ]
Blumberg, Henry M. [1 ,2 ,3 ]
机构
[1] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
[2] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
[3] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA
[4] Natl Ctr TB & Lung Dis, Tbilisi, Georgia
来源
PLOS ONE | 2014年 / 9卷 / 04期
关键词
TREATMENT OUTCOMES; PREDICTORS; ASSOCIATION; IMPACT; RISK;
D O I
10.1371/journal.pone.0094890
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: Diabetes mellitus (DM) is a risk factor for active tuberculosis (TB) but little is known about the effect of DM on culture conversion among patients with multidrug-resistant (MDR)-TB. The primary aim was to estimate the association between DM and rate of TB sputum culture conversion. A secondary objective was to estimate the association between DM and the risk of poor treatment outcomes among patients with MDR-TB. Materials and Methods: A cohort of all adult patients starting MDR-TB treatment in the country of Georgia between 20092011 was followed during second-line TB therapy. Cox proportional models were used to estimate the adjusted hazard rate of sputum culture conversion. Log-binomial regression models were used to estimate the cumulative risk of poor TB treatment outcome. Results: Among 1,366 patients with sputum culture conversion information, 966 (70.7%) had culture conversion and the median time to conversion was 68 days (interquartile range 50-120). The rate of conversion was similar among patients with MDR-TB and DM (adjusted hazard ratio [aHR] 0.95, 95% CI 0.71-1.28) compared to patients with MDR-TB only. The rate of culture conversion was significantly less in patients that currently smoked (aHR 0.82, 95% CI 0.71-0.95), had low body mass index (aHR 0.71, 95% CI 0.59-0.84), second-line resistance (aHR 0.56, 95% CI 0.43-0.73), lung cavities (aHR 0.70, 95% CI 0.59-0.83) and with disseminated TB (aHR 0.75, 95% CI 0.62-0.90). The cumulative risk of poor treatment outcome was also similar among TB patients with and without DM (adjusted risk ratio [aRR] 1.03, 95% CI 0.93-1.14). Conclusions: In adjusted analyses, DM did not impact culture conversion rates in a clinically meaningful way but smoking did.
引用
收藏
页数:9
相关论文
共 35 条
  • [21] Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis
    Kurbatova, E. V.
    Gammino, V. M.
    Bayona, J.
    Becerra, M. C.
    Danilovitz, M.
    Falzon, D.
    Gelmanova, I.
    Keshavjee, S.
    Leimane, V.
    Mitnick, C. D.
    Quelapio, M. I.
    Riekstina, V.
    Taylor, A.
    Viiklepp, P.
    Zignol, M.
    Cegielski, J. P.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (10) : 1335 - 1343
  • [22] Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects
    Kurbatova, Ekaterina V.
    Taylor, Allison
    Gammino, Victoria M.
    Bayona, Jaime
    Becerra, Mercedes
    Danilovitz, Manfred
    Falzon, Dennis
    Gelmanova, Irina
    Keshavjee, Salmaan
    Leimane, Vaira
    Mitnick, Carole D.
    Quelapio, Ma Imelda
    Riekstina, Vija
    Viiklepp, Piret
    Zignol, Matteo
    Cegielski, J. Peter
    [J]. TUBERCULOSIS, 2012, 92 (05) : 397 - 403
  • [23] Smoking and 2-month culture conversion during anti-tuberculosis treatment
    Maciel, E. L.
    Brioschi, A. P.
    Peres, R. L.
    Guidoni, L. M.
    Ribeiro, F. K.
    Hadad, D. J.
    Vinhas, S. A.
    Zandonade, E.
    Palaci, M.
    Dietze, R.
    Johnson, J. L.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (02) : 225 - 228
  • [24] Commentary: Co-occurrence of tuberculosis and diabetes: new paradigm of epidemiological transition
    Magee, Matthew J.
    Blumberg, Henry M.
    Narayan, K. M. Venkat
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2011, 40 (02) : 428 - 431
  • [25] Predictors of delayed culture conversion in patients treated for multidrug-resistant tuberculosis in Pakistan
    Qazi, F.
    Khan, U.
    Khowaja, S.
    Javaid, M.
    Ahmed, A.
    Salahuddin, N.
    Hussain, H.
    Becerra, M. C.
    Golub, J. E.
    Khan, A. J.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2011, 15 (11) : 1556 - 1559
  • [26] Short report: Mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetes
    Restrepo, Blanca I.
    Fisher-Hoch, Susan P.
    Smith, Brian
    Jeon, Sangchoon
    Rahbar, Mohammad H.
    McCormick, Joseph B.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2008, 79 (04) : 541 - 544
  • [27] Richards DC, 2006, INT J TUBERC LUNG D, V10, P396
  • [28] Rothman KJ, 2008, Modern Epidemiology, 3rd Edition
  • [29] Cigarette Smoke Increases Susceptibility to Tuberculosis-Evidence From In Vivo and In Vitro Models
    Shang, Shaobin
    Ordway, Diane
    Henao-Tamayo, Marcela
    Bai, Xiyuan
    Oberley-Deegan, Rebecca
    Shanley, Crystal
    Orme, Ian M.
    Case, Stephanie
    Minor, Maisha
    Ackart, David
    Hascall-Dove, Laurel
    Ovrutsky, Alida R.
    Kandasamy, Pitchaimani
    Voelker, Dennis R.
    Lambert, Cherie
    Freed, Brian M.
    Iseman, Michael D.
    Basaraba, Randall J.
    Chan, Edward D.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (09) : 1240 - 1248
  • [30] MULTIDRUG RESISTANT TUBERCULOSIS: ROLE OF PREVIOUS TREATMENT WITH SECOND LINE THERAPY ON TREATMENT OUTCOME
    Singh, R.
    Gothi, D.
    Joshi, J. M.
    [J]. LUNG INDIA, 2007, 24 (02) : 54 - 57